You are here

Black Diamond Therapeutics

Black Diamond’s lung cancer pivot delivers

EP Vantage

Thu, 06/29/23 - 09:56 am

Black Diamond Therapeutics

clinical trials

ASCO 2021 movers – PDS wins, but big pharma reigns

EP Vantage

Wed, 06/9/21 - 11:00 am

PDS Biotechnology

Spectrum Pharma

Black Diamond Therapeutics

Alpine Immune Sciences

Harpoon Therapeutics

ASCO 2021 – the exon 20 army lines up behind Rybrevant

EP Vantage

Mon, 06/7/21 - 11:12 am

exon 20-insertion NSCLC

Dizal Pharmaceutical

Black Diamond Therapeutics

Covid-19 stalls biotech flotations

EP Vantage

Fri, 04/10/20 - 10:26 am

Revolution Medicines

Black Diamond Therapeutics

Beam Therapeutics

The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer

Endpoints

Mon, 01/6/20 - 10:27 am

Black Diamond Therapeutics

I-Mab Biopharma

Black Diamond Gets $85M for Cancer Drugs R&D and New Cambridge HQ

Xconomy

Thu, 01/10/19 - 09:45 am

Black Diamond Therapeutics